Compare MITK & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITK | ORGO |
|---|---|---|
| Founded | 1983 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.1M | 514.0M |
| IPO Year | 1995 | 2016 |
| Metric | MITK | ORGO |
|---|---|---|
| Price | $14.57 | $3.39 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $15.00 | $7.67 |
| AVG Volume (30 Days) | ★ 992.5K | 489.7K |
| Earning Date | 05-13-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 171.43 | ★ 1600.00 |
| EPS | 0.06 | ★ 0.15 |
| Revenue | $45,390,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $9.55 | N/A |
| Revenue Next Year | $7.15 | $10.07 |
| P/E Ratio | $245.67 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $6.93 | $2.61 |
| 52 Week High | $15.15 | $7.08 |
| Indicator | MITK | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 70.56 | 33.08 |
| Support Level | $9.30 | $2.88 |
| Resistance Level | N/A | $3.71 |
| Average True Range (ATR) | 0.64 | 0.21 |
| MACD | 0.23 | 0.00 |
| Stochastic Oscillator | 85.07 | 3.21 |
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.